Trial Profile
Assessment of bronchodilation induced by beta-adrenergic agent and anti-cholinergic agent in COPD patients, using 3D CT Image analysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2016
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 10 Nov 2016 New trial record
- 01 Oct 2016 Results published in the Respiratory Medicine